IL320606A - Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease - Google Patents

Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease

Info

Publication number
IL320606A
IL320606A IL320606A IL32060625A IL320606A IL 320606 A IL320606 A IL 320606A IL 320606 A IL320606 A IL 320606A IL 32060625 A IL32060625 A IL 32060625A IL 320606 A IL320606 A IL 320606A
Authority
IL
Israel
Prior art keywords
group
hydrogen atom
compound
composition
mixture
Prior art date
Application number
IL320606A
Other languages
English (en)
Hebrew (he)
Original Assignee
Dks Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dks Co Ltd filed Critical Dks Co Ltd
Publication of IL320606A publication Critical patent/IL320606A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL320606A 2022-11-04 2023-11-01 Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease IL320606A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022177714 2022-11-04
PCT/JP2023/039446 WO2024096066A1 (ja) 2022-11-04 2023-11-01 中枢神経系損傷疾患を処置または予防するための環状ペプチド誘導体組成物

Publications (1)

Publication Number Publication Date
IL320606A true IL320606A (en) 2025-07-01

Family

ID=90930657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL320606A IL320606A (en) 2022-11-04 2023-11-01 Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease

Country Status (7)

Country Link
EP (1) EP4613282A1 (https=)
JP (1) JPWO2024096066A1 (https=)
KR (1) KR20250111317A (https=)
CN (1) CN120152726A (https=)
IL (1) IL320606A (https=)
TW (1) TW202525320A (https=)
WO (1) WO2024096066A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202547546A (zh) * 2024-02-07 2025-12-16 日商第一工業製藥股份有限公司 用以改善腦功能之環狀肽衍生物組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
DE69839355T2 (de) 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US8889112B2 (en) 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1654002B2 (en) 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
US20050059744A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
WO2016047638A1 (ja) * 2014-09-24 2016-03-31 国立大学法人岩手大学 環状ペプチド誘導体とその製造方法および組成物
JP7486328B2 (ja) * 2020-03-05 2024-05-17 株式会社バイオコクーン研究所 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質
JP7695662B2 (ja) * 2020-11-02 2025-06-19 公立大学法人大阪 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法

Also Published As

Publication number Publication date
JPWO2024096066A1 (https=) 2024-05-10
TW202525320A (zh) 2025-07-01
WO2024096066A1 (ja) 2024-05-10
KR20250111317A (ko) 2025-07-22
EP4613282A1 (en) 2025-09-10
CN120152726A (zh) 2025-06-13

Similar Documents

Publication Publication Date Title
JP7659015B2 (ja) 免疫調節剤としての１，２，４－オキサジアゾールおよびチアジアゾール化合物
CN1100785C (zh) 1,3,4,5－四氢苯并[c]氮杂䓬－3－酮二硫化物衍生物及方法
CN108699078A (zh) 噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法
KR20020063185A (ko) 새로운 당뇨병 치료제
JPH10512257A (ja) 置換オキサゾリジンカルパインおよび／またはカテプシンｂ阻害剤
JP2026016715A (ja) 狂犬病治療のための環状アミド化合物およびその方法
EP4613282A1 (en) Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease
RU2017748C1 (ru) Производные нитратоалкановых кислот или их фармацевтически приемлемые соли
EP4613283A1 (en) Cyclic peptide derivative composition for treating or preventing neuropathic pain and/or inflammatory pain
EP4595973A1 (en) Cyclic peptide derivative composition for treating or preventing eye disease
EP4567042A1 (en) Cyclic peptide derivative, method for producing same, and composition
WO2025169980A1 (ja) テストステロンの産生／分泌を調節するための環状ペプチド誘導体組成物
WO2025169981A1 (ja) 脳機能を改善するための環状ペプチド誘導体組成物
JP2023084946A (ja) 生理活性を有する新規化合物
JPH09157236A (ja) フェニレンジアミン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
JP3129370B2 (ja) 食欲抑制剤
JP2022091476A (ja) 新規含窒素三環性骨格化合物およびその使用
WO2002006227A1 (en) Matrix metalloprotease inhibitors
JP2025509736A (ja) 循環タンパク質を分解するための二官能性分子
CN118459542A (zh) Rgd修饰的双吲哚甲烷衍生物及其制备和应用
JP2023542455A (ja) ３－デオキシ－２－ケトアルドン酸窒素含有誘導体、その製造方法及びその使用
WO2010083633A1 (zh) 抗高血压化合物及其制备方法、药物组合物和用途